Unlike the categorical PAM50 classification of BRCA tumors, the XDec-SM mapping approach places cancer cells on the spectrum between the pure Luminal, Basal and HER2 subtypes (Fig 4A and 4B). This evidence concerns the gene ERBB2 and cancer.